TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Bicara Therapeutics to Present at the J.P. Morgan 2026 Annual Healthcare Conference on Monday, January 12

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Claire Mazumdar
Bicara Therapeutics to Present at the J.P. Morgan 2026 Annual Healthcare Conference on Monday, January 12

Bicara Therapeutics will present at the J.P. Morgan 2026 Healthcare Conference, highlighting its lead program ficerafusp alfa, a bifunctional antibody designed to treat solid tumor cancers by targeting EGFR and TGF-β.

Insights
BCAX   positive

Company is advancing its lead therapeutic candidate ficerafusp alfa, demonstrating consistent response rates and progressing towards pivotal study dose selection in head and neck cancer treatment